AANEM 2025: Conference Review and Analysis for New Data on Emerging BAFF/APRIL Inhibitors for the Management of Patients with Generalized Myasthenia Gravis
The Nephrology Community’s Reception of New Phase 3 Data on Aldosterone Synthase Inhibitors for Difficult-to-Control Hypertension at ESC2025
The Nephrology Community’s Reception of New Phase 3 Data on Aldosterone Synthase Inhibitors for Difficult-to-Control Hypertension at ESC2025
Updates on FcRn Blockers for Patients With Myasthenia Gravis: Personalized Treatment Strategies and Shared Decision Making
Foundational Review of Standards of Care for At-Risk Patients with Dyslipidemia
Foundational Review of Standards of Care for At-Risk Patients with Dyslipidemia
A Primary Care Perspective on the Diagnosis and Treatment of Irritable Bowel Syndrome
Optimizing Care for HCM Patients: Evidence-Based, Pathology-Targeted Management for All
Therapeutic Advances in Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
Therapeutic Advances in Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)